TXG

10 X Genomics Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↑ 7/10
  • Value↓ 2/10
10 X Genomics sales and earnings growth
TXG Growth
Good
  • Revenue Y/Y↑ 5.25%
  • EPS Y/Y↑ 76.97%
  • FCF Y/Y↑ 2371.16%
10 X Genomics gross and profit margin trends
TXG Profitability
Neutral
  • Gross margin ↑ 69.10%
  • EPS margin↓ -6.80%
  • ROIC 5Y↓ -29.08%
10 X Genomics net debt vs free cash flow
TXG Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

10 X Genomics stock volatility is higher than the overall market. We give it a Great risk rating.

More Health Information Services stocks ↗